Rachel C Sharp1, Olajumoke A Effiom2, Anuradha Dhingra1, Onatolu Odukoya2, Adetokunbo Olawuyi2, Godwin T Arotiba3, Kathleen Boesze-Battaglia1, Sunday O Akintoye4. 1. Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia PA USA. 2. Department of Oral and Maxillofacial Pathology/Biology, Faculty of Dental Sciences, University of Lagos, Lagos Nigeria. 3. Department of Oral and Maxillofacial Surgery, Faculty of Dental Sciences, University of Lagos, Lagos Nigeria. 4. Department of Oral Medicine, School of Dental Medicine, University of Pennsylvania, Philadelphia PA USA. Electronic address: akintoye@upenn.edu.
Abstract
OBJECTIVES: Ameloblastoma is an aggressive odontogenic jaw neoplasm. Its unlimited growth confers high potential for malignant transformation and recurrence. It is unclear why ameloblastoma is highly recurrent despite surgical resection with a wide margin of normal tissue. While canonical autophagy can be used to degrade and eliminate damaged cellular components, it is also a protective mechanism that provides energy and vital metabolites for cell survival. We used ameloblastoma-derived cells to test the hypothesis that autophagic processes play a role in survival and reactivation of ameloblastoma. METHODS: Primary epithelial (EP-AMCs) and mesenchymal (MS-AMCs) ameloblastoma-derived cells were established from tissue samples of solid multicystic ameloblastoma. Clonogenic capacity and basal autophagic capacity were assessed in ameloblastoma-derived cells relative to human odontoma-derived cells (HODCs) and maxilla-mesenchymal stem cells (MX-MSCs). Ability of ameloblastoma-derived cells to survive and form new ameloblastoma was assessed in mouse tumor xenografts. RESULTS: EP-AMCs were highly clonogenic (p < 0.0001) and demonstrated enhanced basal levels of autophagic proteins microtubule-associated protein 1-light chain 3 (LC3) (p < 0.01), p62 (Sequestosome 1, SQSTM1) (p < 0.01), and the LC3-adapter, melanoregulin (MREG) (p < 0.05) relative to controls. EP-AMCs xenografts regenerated solid ameloblastoma-like tumor with histological features of columnar ameloblast-like cells, loose stellate reticulum-like cells and regions of cystic degeneration characteristic of follicular variant of solid multicystic ameloblastoma. The xenografts also displayed stromal epithelial invaginations strongly reactive to LC3 and p62 suggestive of epithelial-mesenchymal transition and neoplastic odontogenic epithelium. CONCLUSIONS: EP-AMCs exhibit altered autophagic processes that can support survival and recurrence of post-surgical ameloblastoma cells.
OBJECTIVES:Ameloblastoma is an aggressive odontogenic jaw neoplasm. Its unlimited growth confers high potential for malignant transformation and recurrence. It is unclear why ameloblastoma is highly recurrent despite surgical resection with a wide margin of normal tissue. While canonical autophagy can be used to degrade and eliminate damaged cellular components, it is also a protective mechanism that provides energy and vital metabolites for cell survival. We used ameloblastoma-derived cells to test the hypothesis that autophagic processes play a role in survival and reactivation of ameloblastoma. METHODS: Primary epithelial (EP-AMCs) and mesenchymal (MS-AMCs) ameloblastoma-derived cells were established from tissue samples of solid multicystic ameloblastoma. Clonogenic capacity and basal autophagic capacity were assessed in ameloblastoma-derived cells relative to humanodontoma-derived cells (HODCs) and maxilla-mesenchymal stem cells (MX-MSCs). Ability of ameloblastoma-derived cells to survive and form new ameloblastoma was assessed in mousetumor xenografts. RESULTS: EP-AMCs were highly clonogenic (p < 0.0001) and demonstrated enhanced basal levels of autophagic proteins microtubule-associated protein 1-light chain 3 (LC3) (p < 0.01), p62 (Sequestosome 1, SQSTM1) (p < 0.01), and the LC3-adapter, melanoregulin (MREG) (p < 0.05) relative to controls. EP-AMCs xenografts regenerated solid ameloblastoma-like tumor with histological features of columnar ameloblast-like cells, loose stellate reticulum-like cells and regions of cystic degeneration characteristic of follicular variant of solid multicystic ameloblastoma. The xenografts also displayed stromal epithelial invaginations strongly reactive to LC3 and p62 suggestive of epithelial-mesenchymal transition and neoplastic odontogenic epithelium. CONCLUSIONS: EP-AMCs exhibit altered autophagic processes that can support survival and recurrence of post-surgical ameloblastoma cells.
Authors: Miguel A Sanjuan; Christopher P Dillon; Stephen W G Tait; Simon Moshiach; Frank Dorsey; Samuel Connell; Masaaki Komatsu; Keiji Tanaka; John L Cleveland; Sebo Withoff; Douglas R Green Journal: Nature Date: 2007-12-20 Impact factor: 49.962
Authors: Dinaz Ghandhi; Ashraf F Ayoub; M Anthony Pogrel; Gordon MacDonald; Laetitia M Brocklebank; Khursheed F Moos Journal: J Oral Maxillofac Surg Date: 2006-07 Impact factor: 1.895
Authors: Jennifer Martinez; Johann Almendinger; Andrew Oberst; Rachel Ness; Christopher P Dillon; Patrick Fitzgerald; Michael O Hengartner; Douglas R Green Journal: Proc Natl Acad Sci U S A Date: 2011-10-03 Impact factor: 11.205
Authors: Sunday O Akintoye; Thanh Lam; Songtao Shi; Jaime Brahim; Michael T Collins; Pamela G Robey Journal: Bone Date: 2006-01-03 Impact factor: 4.398
Authors: Matej Krajcovic; Nicole B Johnson; Qiang Sun; Guillaume Normand; Nicholas Hoover; Evelyn Yao; Andrea L Richardson; Randall W King; Edmund S Cibas; Stuart J Schnitt; Joan S Brugge; Michael Overholtzer Journal: Nat Cell Biol Date: 2011-02-20 Impact factor: 28.824